H44.2E2
Degenerative myopia with other maculopathy, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Degenerative myopia, also known as pathological or high myopia, is a severe form of nearsightedness that can lead to significant changes in the eye’s structure, particularly affecting the retina and macula. When degeneration affects the macula in the left eye, it is classified under ICD-10 code H44.2E2. This condition involves progressive deterioration of the eye's internal layers, often resulting in visual impairment. It is essential to understand the underlying factors, associated symptoms, and available management options to better comprehend this eye disorder.
Causes & Symptoms
Clinical Causes: Genetic predisposition: A family history of myopia can increase risk. Excessive near work and prolonged close-up activities that strain the eyes. Environmental factors: Limited outdoor activity during childhood may contribute. Structural eye abnormalities: Abnormally elongated eyeballs common in high myopia. Age-related changes: Degeneration of the retina and other ocular tissues over time. Degenerative processes: Breakdown of retinal tissues leading to maculopathy in severe myopia.
Key Symptoms: Gradual loss of central vision, affecting activities like reading or recognizing faces. Blurred vision, especially for fine details. Presence of visual distortions such as straight lines appearing bent or crooked. Color perception changes or decreased contrast sensitivity. In some cases, the development of dark spots or scotomas in the central vision. Possible sensation of eye discomfort or – in advanced stages – visual field defects.
Diagnostic & Treatment
Diagnosis Path: Visual acuity testing to assess clarity of vision. Refraction assessment to determine the degree of nearsightedness. Fundus examination using dilated pupils to evaluate retinal and macular health. Optical coherence tomography (OCT): An imaging technique providing detailed cross-sectional views of retinal layers. Fundus photography to document structural changes in the retina and macula. Fluorescein angiography: An imaging test that helps identify blood vessel abnormalities and leakage in the retina.
Treatment Protocols: Regular eye examinations to monitor changes and manage complications promptly. Use of personalized corrective lenses to optimize remaining vision. Treatments for specific complications, such as laser therapy for choroidal neovascularization. Anti-VEGF (vascular endothelial growth factor) injections for new abnormal blood vessels that may develop. Low vision aids and rehabilitation services to maximize quality of life, especially in advanced stages. Lifestyle modifications: Protecting eyes from excessive strain, wearing UV protection, and avoiding high-impact activities that increase risk.
Clinical Advice & FAQs
Billing Guidance
Is H44.2E2 a billable ICD-10 code?
Yes, H44.2E2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H44.2E2?
Clinical documentation must specify the nature of Degenerative myopia with other maculopathy, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference